Evidence map›Paper›PMID 40000667›Full record

ArticleNature communications2025

Th1-poised naive CD4 T cell subpopulation reflects anti-tumor immunity and autoimmune disease.

Jae-Won Yoon, Kyung Min Kim, Sookyung Cho, Min-Ji Cho, Seonjun Park, Daehee Hwang, Hye Ryun Kim, Sung Ho Park, Jae-Ho Cho, Hyobin Jeong and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. CD97/Cells · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Adhesion G protein-coupled receptors.Pharmacological reviews · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jae-Won Yoon *Department of Life Science, College of Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.ORCID http://orcid.org/0009-0008-6613-6134
Kyung Min Kim *Department of Biological Sciences, Seoul National University, Seoul, Korea.
Sookyung Cho *Department of Life Science, College of Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.
Min-Ji ChoDepartment of Life Science, College of Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.ORCID http://orcid.org/0000-0002-6090-6651
Seonjun ParkDepartment of Biological Sciences, Ulsan National Institute of Science & Technology (UNIST), Ulsan, Republic of Korea.ORCID http://orcid.org/0000-0001-8871-5059
Daehee HwangDepartment of Biological Sciences, Seoul National University, Seoul, Korea.ORCID http://orcid.org/0000-0002-7553-0044
Hye Ryun KimDivision of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.ORCID http://orcid.org/0000-0002-1842-9070
Sung Ho ParkDepartment of Biological Sciences, Ulsan National Institute of Science & Technology (UNIST), Ulsan, Republic of Korea.
Jae-Ho ChoMedical Research Center for Combinatorial Tumor Immunotherapy, Department of Microbiology and Immunology, Chonnam National University Medical School, Hwasun, 58128, Korea.ORCID http://orcid.org/0000-0002-3081-7674
Hyobin JeongDepartment of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, South Korea. hyobinjeong@yonsei.ac.kr.ORCID http://orcid.org/0000-0002-1526-3343
Je-Min ChoiDepartment of Life Science, College of Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea. jeminchoi@hanyang.ac.kr.ORCID http://orcid.org/0000-0002-9482-710X

Funding

National Research Foundation of Korea (NRF) RS-2023-00217324National Research Foundation of Korea (NRF) RS-2024-00334289National Research Foundation of Korea (NRF) RS-2024-00336518
6 · The paper itself

Abstract

Naïve CD4 T cells are traditionally viewed as a quiescent, homogeneous, resting population, but emerging evidence reveals their heterogeneity, which can be crucial for understanding disease contexts and therapeutic outcomes. In this study, we identify distinct subpopulations within both murine and human naïve CD4 T cells by single cell-RNA-sequencing (scRNA-seq), particularly focusing on a subpopulation that expresses super-high levels of interleukin-7 receptor (IL-7R

Indexed as

Autoimmune DiseasesCD4-Positive T-LymphocytesNeoplasmsTh1 CellsAnimalsFemaleHumansMaleMelanoma, ExperimentalMiceMice, Inbred C57BLMultiple SclerosisProgrammed Cell Death 1 ReceptorReceptors, Interleukin-7Single-Cell AnalysisProgrammed Cell Death 1 ReceptorReceptors, Interleukin-7

Identifiers

PMID40000667
PMCPMC11861895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.